Nine Monkeypox Cases Confirmed in United States
FRIDAY, May 27, 2022 (HealthDay News) -- Nine cases of monkeypox had been confirmed in seven states as of Wednesday, and there are likely to be more cases as a worldwide outbreak continues, U.S. health officials say.
The nine cases of the disease, which does not occur naturally in the United States, were identified in Massachusetts, Florida, Utah, Washington, California, Virginia, and New York, according to the U.S. Centers for Disease Control and Prevention, CNN reported. While the case in Virginia involves a woman, most of the cases "are within gay [and] bisexual men and other men who have sex with men," CDC Director Rochelle Walensky, M.D., said on Thursday.
The approach to the situation needs to be "guided by science, not by stigma," Walensky emphasized, CNN reported. "While some groups may have a greater chance of exposure right now, infectious diseases do not care about state or international borders. They're not contained within social networks, and the risk of exposure is not limited to any one particular group," Walensky explained. "We shouldn't be surprised to see more cases."
The CDC is working to learn how each of the nine patients contracted the virus. Walensky said some have a recent history of international travel to places with active monkeypox outbreaks, but others do not, CNN reported.
The disease is not thought to be easily transmitted, and typically, people pick up monkeypox from an infected animal. When human-to-human transmission occurs, it is usually through close direct contact, such as contact with lesions on the skin or the inhalation of large respiratory droplets. The CDC has told doctors and the public to watch for symptoms of monkeypox, which can include fever, headache, muscle aches, swollen lymph nodes, and lesions or pustules and a rash on the body, including the palms of the hands and the soles of the feet.
There are vaccines for monkeypox and they will be sent where needed, according to Walensky. "One of these vaccines, with the trade name of Jynneos, is approved for the prevention of monkeypox disease in adults 18 years of age and older," Walensky said. "CDC has mechanisms in place to move these products around the country so that they can be used for prevention or treatment for people who may benefit, wherever they may be."
Related Posts
New High-Tech CT Might Expand Heart Imaging
TUESDAY, June 20, 2023 (HealthDay News) -- The benefits of noninvasive imaging...
Hospitalizations Involving Fungal Infections Up During COVID-19
THURSDAY, June 15, 2023 (HealthDay News) -- Increased hospitalizations involving...
Vaccination After SARS-CoV-2 Infection May Cut Long COVID Risk
MONDAY, May 23, 2022 (HealthDay News) -- For adults who test positive for severe...
Short Sleep Duration Linked to Increased Risk for PAD
FRIDAY, March 17, 2023 (HealthDay News) -- Short sleep duration is associated...